Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0038187 (
starvation
)
24,951
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Despite 14-3-3 proteins being implicated in the control of the eukaryotic cell cycle, metabolism, cell signalling and survival, little is known about the global regulation or functions of the phosphorylation-dependent binding of 14-3-3s to diverse target proteins. We identified Arabidopsis cytosolic proteins that bound 14-3-3s in competition with a 14-3-3-binding phosphopeptide, including nitrate reductase, glyceraldehyde- 3-phosphate dehydrogenase, a calcium-dependent protein kinase, sucrose-phosphate synthase (SPS) and glutamyl-tRNA synthetase. Remarkably, in cells starved of sugars or fed with non-metabolizable glucose analogues, all 14-3-3 binding was lost and the target proteins were selectively cleaved into proteolytic fragments. 14-3-3 binding reappeared after several hours of re-feeding with sugars.
Starvation
-induced degradation was blocked by 5-amino imidazole-4-carboxamide riboside (which is converted to an AMP-mimetic) or the protease inhibitor MG132 (Cbz-leu-leu-leucinal). Extracts of sugar-starved (but not sugar-fed) Arabidopsis cells contained an ATP-independent, MG132-sensitive, neutral protease that cleaved Arabidopsis SPS, and the mammalian 14-3-3-regulated transcription factor,
FKHR
. Cleavage of SPS and phosphorylated
FKHR
in vitro was blocked by binding to 14-3-3s. The finding that 14-3-3s participate in a nutrient-sensing pathway controlling cleavage of many targets may underlie the effects of these proteins on plant development.
...
PMID:14-3-3s regulate global cleavage of their diverse binding partners in sugar-starved Arabidopsis cells. 1085 32
The expression and biological function of Nerve Growth Factor (NGF) receptors was studied in a panel of
rhabdomyosarcoma
cell lines derived from embryonal and alveolar histotype. All the cell lines expressed both the high affinity receptor TrkA and the low affinity receptor p75(NTR). Treatment with exogenous NGF did not considerably alter
rhabdomyosarcoma
cell growth or differentiation, but significantly inhibited spontaneous apoptosis as well as apoptosis, and induced by serum
starvation
or apoptosis induced by treatment with cycloheximide (CHX). Rhabdomyosarcoma cell lines expressed NGF and other neurotrophins and trace amounts of NGF protein were found in the supernatants of
rhabdomyosarcoma
cell cultures. Blocking the putative autocrine loop with an anti-NGF antibody resulted in an increase in apoptosis compared with control cultures. These data suggest that the simultaneous presence of both high and low affinity NGF receptors engaged by endogenous or exogenous NGF might contribute to the escape from apoptosis exhibited by the
rhabdomyosarcoma
cells.
...
PMID:An anti-apoptotic role for NGF receptors in human rhabdomyosarcoma. 1152 1
Insulin inhibits the expression of the hepatic insulin-like growth factor-binding protein-1 (IGFBP-1) and glucose-6-phosphatase (G6Pase) genes. The signaling pathway that mediates these events requires the activation of phosphatidylinositol 3-kinase, whereas transfection studies have suggested an involvement of Akt (protein kinase B) and
FKHR
, a transcription factor regulated by Akt. We now demonstrate that insulin repression of endogenous IGFBP-1 gene transcription was blocked by rapamycin or by amino acid
starvation
. Rapamycin inhibited the mammalian target of rapamycin (mTOR) and the subsequent activation of p70/p85 S6 protein kinase-1 (S6K1) by insulin, whereas amino acid depletion prevented insulin induction of these signaling molecules. Importantly, we demonstrate that insulin regulation of the thymine-rich insulin response element of the IGFBP-1 promoter was also inhibited by rapamycin. However, sustained activation of S6K1 did not repress this promoter. In addition, rapamycin did not affect insulin regulation of G6Pase expression or Akt activation. We propose that these observations indicate that an mTOR-dependent, but S6K-independent mechanism regulates the suppression of IGFBP-1 (but not G6Pase) gene expression by insulin. Therefore, although the insulin-responsive sequence of the G6Pase gene promoter is related to that of the IGFBP-1 promoter, the signaling pathways that mediate suppression of these genes are distinct.
...
PMID:Insulin regulation of insulin-like growth factor-binding protein-1 gene expression is dependent on the mammalian target of rapamycin, but independent of ribosomal S6 kinase activity. 1178 21
Expression of the catalytic subunit of glucose-6-phosphatase (G6Pase) has recently been shown to be transactivated by the transcription factor
FKHR
. Insulin and conditions of energy depletion are known repressors of the G6Pase gene. Whereas insulin is known to inhibit G6Pase expression by phosphorylation and nuclear exclusion of
FKHR
, the mechanism of repression of G6Pase by energy depletion is unknown. Here, we have studied the effect of glucose
starvation
and AICAR, an activator of AMP-activated protein kinase (AMPK) on G6Pase expression and the expressional level of
FKHR
-protein in hepatic cells. Using a H4-hepatoma cell line stably overexpressing
FKHR
, we found that both glucose
starvation
and treatment of cells with AICAR strongly repressed G6Pase expression and led to an almost complete disappearance of the
FKHR protein
, whereas the levels of control proteins and
FKHR
mRNA were not affected. Our data suggest that AICAR and glucose
starvation
inhibit G6Pase expression by a reduction of the cellular level of
FKHR
, presumably mediated by specific degradation of the protein.
...
PMID:Regulation of the forkhead transcription factor FKHR (FOXO1a) by glucose starvation and AICAR, an activator of AMP-activated protein kinase. 1213 May 86
Peroxisome proliferator-activated receptor-gamma coactivator-1 (PGC-1) plays a major role in mediating hepatic gluconeogenesis in response to
starvation
, during which PGC-1 is induced by the cyclic AMP response element binding protein. Although it is observed that insulin counteracts PGC-1 transcription, the mechanism by which insulin suppresses the transcription of PGC-1 is still unclear. Here, we show that forkhead transcription factor
FKHR
contributes to mediating the effects of insulin on PGC-1 promoter activity. Reporter assays demonstrate that insulin suppresses the basal PGC-1 promoter activity and that coexpression of protein kinase (PK)-B mimics the effect of insulin in HepG2 cells. Insulin response sequences (IRSs) are addressed in the PGC-1 promoter as the direct target for
FKHR
in vivo. Coexpression of
FKHR
stimulates the PGC-1 promoter activity via interaction with the IRSs, while coexpression of
FKHR
(3A), in which the three putative PKB sites in
FKHR
are mutated, mainly abolishes the suppressive effect of PKB. Whereas deletion of the IRSs prevents the promoter stimulation by
FKHR
, that activity is still partially inhibited by insulin. These results indicate that signaling via PKB to
FKHR
can partly account for the effect of insulin to regulate the PGC-1 promoter activity via the IRSs.
...
PMID:Regulation of PGC-1 promoter activity by protein kinase B and the forkhead transcription factor FKHR. 1260 3
Activation of the transcription factor
FKHR
(Forkhead in human
rhabdomyosarcoma
, FOXO1a) in various established cell lines induces cell cycle arrest followed by apoptosis. These effects are inhibited through activation of the phosphatidylinositol 3-kinase/Akt pathway, resulting in
FKHR
phosphorylation and its export from the nucleus, thus blocking its pro-apoptotic activity. Here we report that
FKHR
regulates fusion of differentiating primary myoblasts. We demonstrate that
FKHR
is localized in the cytoplasm of proliferating myoblasts, yet translocates to the nucleus by a phosphorylation-independent pathway following serum
starvation
, a condition that induces myoblast differentiation.
FKHR
phosphorylation during terminal differentiation appears to downregulate its fusion activity, as a dominant-active non-phosphorylatable
FKHR
mutant dramatically augments the rate and extent of myotube fusion. However, this
FKHR
mutant exerts its effects only after other events initiated the differentiation pro cess. Conversely, enforced expression of a dominant-negative
FKHR
mutant blocks myotube formation whereas wild-type
FKHR
has no effect. We conclude that in addition to the role of FoxO proteins in regulating cell cycle progress and apoptosis,
FKHR
controls the rate of myotube fusion during myogenic differentiation.
...
PMID:FKHR (FOXO1a) is required for myotube fusion of primary mouse myoblasts. 1260 79
Hepatic gluconeogenesis is absolutely required for survival during prolonged fasting or
starvation
, but is inappropriately activated in diabetes mellitus. Glucocorticoids and glucagon have strong gluconeogenic actions on the liver. In contrast, insulin suppresses hepatic gluconeogenesis. Two components known to have important physiological roles in this process are the forkhead transcription factor
FOXO1
(also known as
FKHR
) and peroxisome proliferative activated receptor-gamma co-activator 1 (PGC-1alpha; also known as PPARGC1), a transcriptional co-activator; whether and how these factors collaborate has not been clear. Using wild-type and mutant alleles of
FOXO1
, here we show that PGC-1alpha binds and co-activates
FOXO1
in a manner inhibited by Akt-mediated phosphorylation. Furthermore,
FOXO1
function is required for the robust activation of gluconeogenic gene expression in hepatic cells and in mouse liver by PGC-1alpha. Insulin suppresses gluconeogenesis stimulated by PGC-1alpha but co-expression of a mutant allele of
FOXO1
insensitive to insulin completely reverses this suppression in hepatocytes or transgenic mice. We conclude that
FOXO1
and PGC-1alpha interact in the execution of a programme of powerful, insulin-regulated gluconeogenesis.
...
PMID:Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1alpha interaction. 1702 43
A forkhead-type transcription factor, DAF-16, is located in the most downstream part of the insulin signalling pathway via PI3K (phosphoinositide 3-kinase). It is essential for the extension of life-span and is also involved in dauer formation induced by food deprivation in Caenorhabditis elegans. In the present study, we addressed whether or not FOXO members AFX,
FKHR
(forkhead homologue in
rhabdomyosarcoma)
and FKHRL1 (
FKHR
-like protein 1), mammalian counterparts of DAF-16, are involved in
starvation
stress. We found a remarkable selective induction of
FKHR
and FKHRL1 transcripts in skeletal muscle of mice during
starvation
. The induction of
FKHR
gene expression was observed at 6 h after food deprivation, peaked at 12 h, and returned to the basal level by 24 h of refeeding. The induction was also found in skeletal muscle of mice with glucocorticoid treatment. Moreover, we found that the levels of PDK4 (pyruvate dehydrogenase kinase 4) gene expression were up-regulated through the direct binding of
FKHR
to the promoter region of the gene in C2C12 cells. These results suggest that
FKHR
has an important role in the regulation of energy metabolism, at least in part, through the up-regulation of PDK4 gene expression in skeletal muscle during
starvation
.
...
PMID:Forkhead transcription factor FOXO1 (FKHR)-dependent induction of PDK4 gene expression in skeletal muscle during energy deprivation. 1282 Sep
Murine L6 and human
rhabdomyosarcoma
cells were cultured standardized in low (0.28 mM) and normal (9 mM) amino acid (AA) concentrations to reevaluate by independent methods to what extent AA activate initiation of protein synthesis. Methods used were incorporation of radioactive AA into proteins, distribution analysis of RNA in density gradient, and Western blots on initiation factors of translation of proteins in cultured cells as well as in vivo (gastrocnemius, C57Bl mice) during
starvation
/refeeding. Incorporation rate of AA gave incorrect results in a variety of conditions, where phenylalanine stimulated the incorporation rate of phenylalanine into proteins, but not of tyrosine, and tyrosine stimulated incorporation of tyrosine but not of phenylalanine. Similar problems were observed when [35S]methionine was used for labeling of fractionated cellular proteins. However, the methods entirely independent of labeled AA incorporation indicated that essential AA activate initiation of translation, whereas nonessential AA did not. Branched-chain AA and glutamine, in combination with some other AA, also stimulated initiation of translation.
Starvation
/refeeding in vitro agreed qualitatively with results in vivo evaluated by initiation factors. Insulin at physiological concentrations (100 microM/ml) did not stimulate global protein synthesis at low or normal AA concentrations but did so at supraphysiological levels (3 mU/ml), confirmed by independent methods. Our results reemphasize that labeled AA should be used with caution for quantification of protein synthesis, since the precursor pool(s) for protein synthesis is not in complete equilibrium with surrounding AA. "Flooding" tracee experiments did not overcome this problem.
...
PMID:Reevaluation of amino acid stimulation of protein synthesis in murine- and human-derived skeletal muscle cells assessed by independent techniques. 1559 73
The insulin signaling pathway, which is conserved in evolution from flies to humans, evolved to allow a fast response to changes in nutrient availability while keeping glucose concentration constant in serum. Here we show that, both in Drosophila and mammals, insulin receptor (InR) represses its own synthesis by a feedback mechanism directed by the transcription factor dFOXO/
FOXO1
. In Drosophila, dFOXO is responsible for activating transcription of dInR, and nutritional conditions can modulate this effect.
Starvation
up-regulates mRNA of dInR in wild-type but not dFOXO-deficient flies. Importantly,
FOXO1
acts in mammalian cells like its Drosophila counterpart, up-regulating the InR mRNA level upon fasting. Mammalian cells up-regulate the InR mRNA in the absence of serum, conditions that induce the dephosphorylation and activation of
FOXO1
. Interestingly, insulin is able to reverse this effect. Therefore, dFOXO/
FOXO1
acts as an insulin sensor to activate insulin signaling, allowing a fast response to the hormone after each meal. Our results reveal a key feedback control mechanism for dFOXO/
FOXO1
in regulating metabolism and insulin signaling.
...
PMID:Transcriptional feedback control of insulin receptor by dFOXO/FOXO1. 1623 May 33
1
2
3
Next >>